The FDA approved Lantidra, the first cellular therapy for the treatment of adults with type 1 diabetes who are unable to approach average blood glucose levels because of current repeated episodes of severe hypoglycemia despite intensive diabetes management and education.
via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/eOxrlNP
No comments:
Post a Comment